Cite
HARVARD Citation
Ellingson, B. et al. (2022). Volumetric measurements are preferred in the evaluation of mutant IDH inhibition in non-enhancing diffuse gliomas: Evidence from a phase I trial of ivosidenib. Neuro-oncology. 24 (5), pp. 770-778. [Online].